まとめ
キルステン (Ki) - ラス遺伝子の異なる変異は,それを活性化させ,癌につながる可能性があります. 研究者らは,ほとんどのヒトのKi-ras mRNAがユニークなコーディングエクソンを使用し,一部の癌細胞は活性化された遺伝子の2つのコピーを持っていることを発見しました.
科学分野:
- 分子生物学は分子生物学である.
- 腫瘍学 腫瘍学
- 遺伝学 遺伝学とは
背景:
- キルステン (Ki) - ラス遺伝子は,ヒトの癌で頻繁に活性化されます.
- キラスの活性化のメカニズムの理解は,がん研究にとって極めて重要です.
研究 の 目的:
- ヒトの肺および結腸がんにおけるKi-ras遺伝子活性化の分子基礎を調査する.
- 癌細胞系におけるc-Ki-ras2遺伝子の特定の変異とmRNAの使用を分析する.
主な方法:
- ヒトがん細胞系からキルステン (Ki) -ラスのcDNAクローンを作る.
- c-Ki-ras2遺伝子のDNA配列解析について.
- 遺伝子の活性化を評価するためのトランスフェクション研究.
主要な成果:
- c-Ki-ras2遺伝子を活性化できる同じコドンでの異なる点変異を特定しました.
- ほとんどのヒトのc-Ki-ras2 mRNAが,ウイルス同類と異なる4番目のコーディングエクソンからの配列を使用することを実証しました.
- 少なくとも1つの細胞系で活性化された遺伝子の機能的同胞性の証拠が見つかりました.
結論:
- c-Ki-ras2遺伝子の特定の点変異は,がんの主要な原動力である.
- 人間のc-Ki-ras2遺伝子発現には,ウイルスのras遺伝子とは異なるユニークなエクソンが含まれています.
- 活性化されたc-Ki-ras2遺伝子の遺伝子複製 (同胞性) は,がんの進行に役割を果たす可能性があります.
さらに関連する動画
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
関連する概念動画
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...